Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma

Published:2023-11-23 Issue:12 Volume:16 Page:1211-1220
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Lear John T.¹²,Morris Linda M.³,Ness Dylan B.³,Lewis Lionel D.³

Affiliation:

1. Manchester Academic Health Science Centre, University of Manchester, Manchester, UK

2. Dermatology Center, Salford Royal NHS Foundation Trust, Salford, UK

3. Department of Medicine, The Geisel School of Medicine & The Dartmouth Cancer Center, Lebanon, NH, USA

Funder

Sun Pharma

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2285849

Reference103 articles.

1. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012

2. Epidemiology of skin cancer;Leiter U;Adv Exp Med Biol,2014

3. Guidelines of care for the management of basal cell carcinoma

4. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

5. Version 2023 1 2023 NCCN Clinical Practice Guidelines® in oncology: basal cell skin cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP